In this episode of the Business of HLTH Podcast, we step inside the world of biotech innovation, where science, capital, and patient care collide.
Natalie sits down with Dr. Shalabh Gupta, Founder and CEO of Unicycive Therapeutics, whose journey spans clinical medicine, Wall Street, and the frontlines of drug development. Driven by firsthand experience treating patients, Dr. Gupta set out to tackle a critical gap in chronic kidney disease care, building a company focused on delivering practical, patient-centered solutions at scale.
With Unicycive’s lead therapeutic now under FDA review, this conversation offers a rare look at what it truly takes to bring a drug from concept to potential approval. From navigating regulatory setbacks to building credibility with investors and clinicians, Dr. Gupta shares the realities behind biotech entrepreneurship and why solving the right problem matters more than anything else.
If you’re interested in the intersection of medicine, innovation, and the business of bringing life-changing therapies to market, this is a conversation you won’t want to miss.
